This document provides a factual overview of the Federal Circuit’s decision in Arthrex v. Smith & Nephew, discusses the court’s remedy, and addresses implications for litigants with Patent Trial and Appeal Board cases pending at the Federal Circuit and at the PTAB itself. The discussion below is current as of November 25, 2019.
Please see full publication below for more information.